Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. - Wikidata - wikimedia - TriplyDB

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

http://www.wikidata.org/entity/Q51739537

about

Current trends in inflammatory bowel disease: the natural history Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?The Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment Response Faecal calprotectin: Management in inflammatory bowel disease Disease monitoring in inflammatory bowel disease Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease Impact of medical therapies on inflammatory bowel disease complication rate Optimising monitoring in the management of Crohn's disease: a physician's perspective Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's disease.Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.Discontinuation of Scheduled Infliximab in Crohn's Patients With Clinical Remission: A Retrospective Single-Center Study.Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target.Measuring disease activity in Crohn's disease: what is currently available to the clinician.Capsule endoscopy: High negative predictive value in the long term despite a low diagnostic yield in patients with suspected Crohn's disease.Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies.Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis Is the disease course predictable in inflammatory bowel diseases?Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.Medical management of Crohn's disease.Characterization of lymphoid follicles with red ring signs as first manifestation of early Crohn's disease by conventional histopathology and confocal laser endomicroscopy.Management of active Crohn disease.A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases.Mucosal healing did not predict sustained clinical remission in patients with IBD after discontinuation of one-year infliximab therapy.Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn's disease regardless of anti-tumor necrosis factor alpha treatment Enteral nutrition in Crohn's disease: an underused therapy.Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.Colon capsule endoscopy: Advantages, limitations and expectations. Which novelties?Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn's disease: recommendations for clinical trial design.Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.Predictors of aggressive inflammatory bowel disease.Mucosal healing in inflammatory bowel disease-a true paradigm of success?PillCam COLON 2 in Crohn's disease: A new concept of pan-enteric mucosal healing assessment Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.Clinical utility of a new endoscopic scoring system for Crohn's disease

P2860

Q24629009-EC53FC7B-E757-4F3A-B136-D696DC55E11A Q26765352-0BC68DDD-B057-4369-9C40-30EE077A745A Q26773129-00067C86-2570-4D00-B35B-440EBF36F7A6 Q26776145-8DA56518-94CE-4CB5-827A-DFB5455774CB Q26777553-18018A78-8C87-44A5-A382-5955199FC272 Q26822029-1D688F3A-81DA-4980-9126-2A3EBF4B0D25 Q26827444-4DC2844B-7071-4CF5-86DB-B40F5F446AA2 Q26829488-81D4ACF0-8FE9-45E7-8F38-4988BA7392DE Q26866940-297663BD-3A6E-4B56-9A28-791D24E9F6B0 Q26995479-8C6C4827-B68E-45A7-982B-82337666909C Q27007083-35A6E63C-BB6A-458C-BEF6-6A0D7DC3D4CD Q27008246-EE913A9B-E0B5-49DA-B809-6CB3D88098C7 Q27323264-9E388185-D59C-459C-A0AA-C0F52FFFD350 Q33564132-254AFB4D-A6A6-4FBE-A1F4-30445D3F9D24 Q33625252-24CD2598-706F-4A5C-9479-FD5CF44E5379 Q33656852-D9AFFE37-9B8F-4D5D-8675-6E38D969F013 Q33668961-8E1DA27D-B06A-497C-89FD-755039A299E9 Q33695305-B8A4F83A-AFF8-419E-819E-60673D86823D Q33763285-1E32C5CF-9B28-4236-83B8-1716503E0232 Q33819484-AF386D82-5B4C-4AA7-B78E-2585088BF32B Q33840425-344DDEC4-7E01-4E83-897E-137ECB604F65 Q33894191-9D11BE47-59B9-4F8D-8CA6-97BD4E21239E Q33944190-F0B75A26-E554-425D-899B-E983182FD545 Q34046139-6316A080-D0BF-4374-AA53-416463BA9CBC Q34342534-411DE2BE-73EB-4065-B351-58240C6F6351 Q34345967-14E10566-D43E-4233-81E3-7F6074C1792B Q34353032-5D1F5D7C-BC60-44DB-9E93-C2E74324CBBE Q34374449-E0D46ACD-3492-4A49-94DC-D0D7D5D73B2E Q34388571-9499A540-AD48-4630-A1FE-F60F31C332F4 Q34395233-350E9669-9343-4F63-80F0-DA12F5625723 Q34431219-8AFFA9A1-F98D-4753-BF24-1C05498FA852 Q34637725-E581D591-A3FE-4075-9F8C-475A0A85CFE1 Q34779205-7B47E84A-373B-46D4-AF85-FC0616FC57AB Q35207745-DAC67884-E2F9-4701-844E-4955506AE29A Q35670809-309EA9E2-2648-4649-8850-BD43E94A6C77 Q35691407-AA1436E6-8F4E-4669-B7A6-727229A2FC92 Q35749943-8C546362-314D-42F5-A573-7395714281DC Q35767904-7821CEE8-1220-442B-883F-797BE5FFB95B Q36009845-BAF79E55-10F5-4421-A832-6C1090CF7F59 Q36050517-A6D41733-F4F4-48CC-9F06-38C3C595D66E

P2860

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

http://www.wikidata.org/entity/Q51739537

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Mucosal healing predicts long- ...... infliximab in Crohn's disease.

@en

Mucosal healing predicts long- ...... infliximab in Crohn's disease.

@nl

type

label

Mucosal healing predicts long- ...... infliximab in Crohn's disease.

@en

Mucosal healing predicts long- ...... infliximab in Crohn's disease.

@nl

prefLabel

Mucosal healing predicts long- ...... infliximab in Crohn's disease.

@en

Mucosal healing predicts long- ...... infliximab in Crohn's disease.

@nl

P1433

Q51739537-8E505FED-7451-4B22-9382-B242F130CD3D

P1476

Q51739537-F598B37B-A5AC-40F6-988E-A4601F12CC7F

P2093

Q51739537-02566208-F308-4D0E-A1B1-9BDA4799A062

Q51739537-4187C4CC-E632-495F-A38A-E227F4C04045

Q51739537-673A488E-E422-4F48-AB0E-445F2FD968C5

Q51739537-6D094E63-7163-440D-8675-FFBBABDD1AC5

Q51739537-B2C022E9-C34E-4DB5-95C8-1F2BA7C3DCAD

Q51739537-DD153D46-9F2C-40DC-ABFC-93D1C930A662

Q51739537-EA75D974-0A0B-47C9-830B-D0DF93266D0D

P304

Q51739537-286455BF-5041-4427-8210-EF4476DB4C65

P31

Q51739537-BE51752C-2F03-412B-9F5C-02BBB8608177

P356

Q51739537-400043C8-AB23-45E2-AE1E-2174F2A5C544

P433

Q51739537-C0E42F64-C511-44A2-B79B-24B7D9695516

P478

Q51739537-5805A378-8496-41D3-85D4-1445AE851001

P50

Q51739537-A290AA8C-642D-4E84-A2D8-83393FCE6DB0

Q51739537-DAEFB93F-7309-4109-AC93-43DE38188368

Q51739537-FFD08225-0164-47D6-BDBF-D693AEB8F7B8

P577

Q51739537-AD19315B-9A96-400F-A217-7C4C02246F87

P5875

Q51739537-9D7E6B25-5D66-4E2B-B373-49D3F87A138D

P698

Q51739537-988A1B0F-4F91-4051-BE69-13D716B7BC57

P356

P1433

Inflammatory Bowel Diseases

P1476

Mucosal healing predicts long- ...... infliximab in Crohn's disease.

@en

P2093

Fabian Schnitzler

http://www.w3.org/2001/XMLSchema#string

Herma Fidder

http://www.w3.org/2001/XMLSchema#string

Ilse Hoffman

http://www.w3.org/2001/XMLSchema#string

Ingrid Arijs

http://www.w3.org/2001/XMLSchema#string

Kristel Van Steen

http://www.w3.org/2001/XMLSchema#string

Maja Noman

http://www.w3.org/2001/XMLSchema#string

Marc Ferrante

http://www.w3.org/2001/XMLSchema#string

P304

1295-1301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.20927

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Séverine Vermeire

Gert Van Assche

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24252475

http://www.w3.org/2001/XMLSchema#string

P698

19340881

http://www.w3.org/2001/XMLSchema#string